Pharmacokinetics, Safety and Tolerability of BI 671800 HEA Given Over 7 Days. A Randomised, Double Blind, Placebo Controlled Within Dose Groups Phase I Study in Healthy Male and Female Volunteers.
PHASE1
The main objectives of the multiple dose study are to investigate the safet...
Status
Completed
Location
1268.59.1 Boehringer Ingelheim Investigational Site
Randomized, Placebo Controlled, Crossover Study in an Environmental Challenge Chamber to Assess Safety & Efficacy of Three Oral Doses of BI 671800 Versus Fluticasone Propionate and Montelukast in Sensitive Seasonal Allergic Rhinitis Patients Out of Season
PHASE2
The objective of the current study is to investigate the efficacy, safety a...
Status
Completed
Location
1268.41.49001 Boehringer Ingelheim Investigational Site